Q2 2025 Humana AB Earnings Call Transcript
Key Points
- Humana AB (FRA:47H) reported underlying profitability improvements in both Sweden and Norway.
- The company has signed several contracts amounting to about SEK100 million in annual revenue, indicating strong future growth.
- A new financing agreement is expected to reduce financial costs by SEK35 million annually.
- Strong cash flow and a decrease in net debt were reported, alongside share repurchases.
- The company is focusing on specialization strategy and organic growth, particularly in high-margin areas.
- Finland's performance was weak due to divestment of Elderly Care and weak purchasing behavior in open care.
- There was a significant negative effect from the Easter holiday, impacting EBIT by SEK27 million.
- The HVB segment in Sweden continues to be weak, with lower occupancy compared to the previous year.
- Organic growth showed a negative development, and the EBIT margin decreased in the quarter.
- The transition in Finland is ongoing and may take time to show significant improvements.
Thank you. Good morning, and welcome to Humana's Q2 presentation. My name is Ewelina Pettersson, I'm the Head of IR at Humana. With me today, I have our CEO, Nathalie Boulas Nilsson; and our CFO, Christoffer Herou. Please go ahead, Nathalie.
Thank you, Ewelina. Starting off with a few highlights from the quarter. We have an underlying profitability improvement in both Sweden and Norway performing well in those areas. We have an ongoing transition in Finland during the quarter. We have performed a Phase 2 of our transition program that we have talked about previously, in previous quarter report, and that will start taking effect from the second half of this year.
We had good performance in all of our targeted growth areas, and this is a very good sign for the future. We are performing very nicely within the LSS segment in Sweden. We're performing nicely in our disability segment in Finland, and we are also performing well in our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
